Telehealth in Chronic Diseases Monitoring Focus on Diabetes, Hypertension and Pulmonary
  • Author(s): Olayiwola Zainab Ajoke ; Popoola Feyisayo Favour ; Eneyo Aya-afon Efre ; Erorun Mofe ; Agwasim Sarah Ngozi; Kawojue Ismail Temitayo
  • Paper ID: 1706891
  • Page: 714-728
  • Published Date: 05-02-2025
  • Published In: Iconic Research And Engineering Journals
  • Publisher: IRE Journals
  • e-ISSN: 2456-8880
  • Volume/Issue: Volume 8 Issue 7 January-2025
Abstract

Background Chronic diseases such as diabetes, hypertension, and pulmonary conditions significantly contribute to global morbidity and mortality. Managing these conditions requires consistent monitoring, timely interventions, and patient engagement, which traditional healthcare models often fail to provide. Telehealth, leveraging digital communication technologies, offers transformative potential in chronic disease management by improving accessibility, real-time monitoring, and personalized care. Despite growing evidence of telehealth's efficacy, a systematic analysis comparing its impact across these chronic conditions remains underexplored. Methodology A systematic review was conducted to evaluate the effectiveness of telehealth interventions in managing diabetes, hypertension, and pulmonary conditions. A comprehensive search strategy was applied to four databases: PubMed, Scopus, Web of Science, and Google Scholar. The inclusion criteria focused on studies evaluating telehealth technologies, such as remote monitoring and virtual consultations, published between 2010 and 2024. Data on study design, interventions, and outcomes were extracted and synthesized thematically to compare telehealth's impact across the three diseases. Results The review included 11 studies representing diverse geographic regions and healthcare settings. Telehealth interventions improved glycemic control in diabetes, reducing HbA1c levels by 0.5%–0.9%. In hypertension, telemonitoring led to a mean systolic blood pressure reduction of 10 mmHg and diastolic reduction of 6 mmHg. For pulmonary conditions, telehealth reduced hospital admissions by 25% and emergency visits by 40%, with a 12% improvement in lung function (FEV1). Common benefits included enhanced patient adherence, reduced healthcare utilization, and improved satisfaction. However, challenges such as technological barriers, adherence sustainability, and provider training were noted. Conclusion Telehealth demonstrates significant efficacy in managing chronic diseases, improving clinical outcomes, patient engagement, and healthcare accessibility. While its integration into healthcare systems shows promise, addressing implementation challenges, including infrastructure and training, is essential for maximizing its potential. Future research should explore long-term sustainability, cost-effectiveness, and integration with emerging technologies to optimize telehealth interventions in chronic disease management.

Keywords

Telehealth, Diabetes Management, Hypertension Control, Pulmonary Monitoring, Chronic Disease Management, Systematic Review.

Citations

IRE Journals:
Olayiwola Zainab Ajoke , Popoola Feyisayo Favour , Eneyo Aya-afon Efre , Erorun Mofe , Agwasim Sarah Ngozi; Kawojue Ismail Temitayo "Telehealth in Chronic Diseases Monitoring Focus on Diabetes, Hypertension and Pulmonary" Iconic Research And Engineering Journals Volume 8 Issue 7 2025 Page 714-728

IEEE:
Olayiwola Zainab Ajoke , Popoola Feyisayo Favour , Eneyo Aya-afon Efre , Erorun Mofe , Agwasim Sarah Ngozi; Kawojue Ismail Temitayo "Telehealth in Chronic Diseases Monitoring Focus on Diabetes, Hypertension and Pulmonary" Iconic Research And Engineering Journals, 8(7)